Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.
Third-quarter GAAP diluted EPS of $0.94 and adjusted diluted EPS of $1.21, which excludes specified items. Abbott maintains its full-year 2024 organic sales growth guidance range ...
Breakthrough stem cell transplants for diabetes have allowed patients to produce their own insulin, offering hope for a ...
DexCom, Inc. (NASDAQ:DXCM) has also consistently beat EPS estimates in the last 4 quarters. The stock has received an average ...
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...
Diet and exercise have always proven effective for weight loss, but some supplements can help speed the process. We think ...
Since the initial release of Open AI’s Chat GPT in 2022, the adoption of artificial intelligence (AI) technology has spread ...
Since the initial release of Open AI’s Chat GPT in 2022, the adoption of artificial intelligence (AI) technology has spread across the world, growing to encompass every industry thanks to its ability ...
What I ultimately learned about bougie health care with expensive equipment and additional testing: Be careful what you wish ...
Understanding your glucose response to the food you eat can play a crucial role in preventing post-meal fatigue.
Continuous glucose monitors (CGM), once exclusive to diabetics, are now available over-the-counter, opening new possibilities ...
We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where ...